Welcome

The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.

Centers

Institut de Pharmacologie de Sherbrooke (IPS)

Institut de Pharmacologie de Sherbrooke focuses on the discovery of new drugs and new diagnostic agents , as well as the validation of emerging drug targets and new technologies to support drug discovery. Major areas of focus include cardiovascular d...

View all

Partnerships

JDRF & Novo Nordisk to Collaborate on Type 1 Diabetes

JDRF and Novo Nordisk have entered into collaboration to develop new immunotherapies to treat Type 1 diabetes. The new partnership will be based out of Novo's newly opened Type 1 Diabetes R&D Center in Seattle. JDRF and Novo Nordisk will be fo...

View all

Jobs

    No Job Posts

Sponsors

Roche Phizer Sigma-Aldrich HL Xenotech Xenotech Eurofins Roche Phizer Sigma-Aldrich HL Xenotech Xenotech Eurofins
View All